System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Studies

Observational Recruiting

NCT04809506 on ClinicalTrials.gov

Identification of New Biomarkers for the Prediction of Cardiovascular Events

Official title: Bio-collection for the Discovery of New Biomarkers for the Prediction of Cardiovascular Events

  • Sponsor: Hôpital Rangueil
  • Enrollment: 1500 (Estimated)
  • Study start: 2021-02-04 (Actual)
  • Primary completion: 2030-02-03 (Estimated)
  • Study completion: 2034-02-03 (Estimated)
  • Allocation: N/a
  • InterventionModel: N/a
  • Masking: None
  • PrimaryPurpose: Other

Brief Summary

The main goal of this project is to constitute a collection of biological samples, obtained through the clinical activity of the Centre for Screening and Prevention of Atherosclerosis at Toulouse University Hospital, managing patients in primary or secondary prevention for cardiovascular (CV) diseases. The main objective is to validate new biomarkers with prognostic value regarding the onset of future CV events. Besides, the biological collection will enable patho-physiological studies on atherosclerosis related diseases.

Conditions

  • Cardiovascular Diseases

Intervention / Treatment

  • Biological: additional blood samples

Primary Outcome Measures

  • measurement of the candidate biomarker (Day 0)
    measurement, at baseline of the candidate biomarker, with respect to the onset, during follow-up, of a cardiovascular event: either coronary events or cerebrovascular stroke or lower limb arteriopathy.
  • measurement of the candidate biomarker (during the intervention/procedure/surgery)
    measurement, at baseline of the candidate biomarker, with respect to the onset, during follow-up, of a cardiovascular event: either coronary events or cerebrovascular stroke or lower limb arteriopathy.

Countries

France

Locations and Investigators

Study Officials